The PAR2 signal peptide prevents premature receptor cleavage and activation

被引:4
|
作者
Liu, Belinda [1 ,2 ]
Lee, Grace [1 ]
Wu, Jiejun [1 ]
Deming, Janise [1 ]
Kuei, Chester [1 ]
Harrington, Anthony [1 ]
Wang, Lien [1 ]
Towne, Jennifer [1 ]
Lovenberg, Timothy [1 ]
Liu, Changlu [1 ]
Sun, Siquan [1 ]
机构
[1] Janssen Res & Dev LLC, San Diego, CA 92121 USA
[2] Univ Calif San Diego, Revelle Coll, San Diego, CA 92103 USA
来源
PLOS ONE | 2020年 / 15卷 / 02期
关键词
CELL-CYCLE; PROTEIN COMPARTMENTALIZATION; FUNCTIONAL-SIGNIFICANCE; ENDOPLASMIC-RETICULUM; EXPRESSION; MEMBRANE; TRANSLOCON; PROTEASES; PROTEOLYSIS; MECHANISM;
D O I
10.1371/journal.pone.0222685
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Unlike closely related GPCRs, protease-activated receptors (PAR1, PAR2, PAR3, and PAR4) have a predicted signal peptide at their N-terminus, which is encoded by a separate exon, suggesting that the signal peptides of PARs may serve an important and unique function, specific for PARs. In this report, we show that the PAR2 signal peptide, when fused to the N-terminus of IgG-Fc, effectively induced IgG-Fc secretion into culture medium, thus behaving like a classical signal peptide. The presence of PAR2 signal peptide has a strong effect on PAR2 cell surface expression, as deletion of the signal peptide (PAR2 Delta SP) led to dramatic reduction of the cell surface expression and decreased responses to trypsin or the synthetic peptide ligand (SLIGKV). However, further deletion of the tethered ligand region (SLIGKV) at the N-terminus rescued the cell surface receptor expression and the response to the synthetic peptide ligand, suggesting that the signal peptide of PAR2 may be involved in preventing PAR2 from intracellular protease activation before reaching the cell surface. Supporting this hypothesis, an Arg36Ala mutation on PAR2SP, which disabled the trypsin activation site, increased the receptor cell surface expression and the response to ligand stimulation. Similar effects were observed when PAR2 Delta SP expressing cells were treated with protease inhibitors. Our findings indicated that there is a role of the PAR2 signal peptide in preventing the premature activation of PAR2 from intracellular protease cleavage before reaching the cells surface. The same mechanism may also apply to PAR1, PAR3, and PAR4.
引用
收藏
页数:21
相关论文
共 50 条
  • [1] Endothelial PAR2 activation evokes resistance artery relaxation
    Zhang, Xun
    Lee, Matthew D.
    Buckley, Charlotte
    Hollenberg, Morley D.
    Wilson, Calum
    McCarron, John G.
    JOURNAL OF CELLULAR PHYSIOLOGY, 2023, 238 (04) : 776 - 789
  • [2] Acanthamoeba proteases contribute to macrophage activation through PAR1, but not PAR2
    Cano, Antonella
    Mattana, Antonella
    Henriquez, Fiona L.
    Alexander, James
    Roberts, Craig W.
    PARASITE IMMUNOLOGY, 2019, 41 (02)
  • [3] Protease-activated receptor 2 (PAR2)-targeting peptide derivatives for positron emission tomography (PET) imaging
    LeSarge, Jordan C.
    Thibeault, Pierre
    Yu, Lihai
    Childs, Marina D.
    Mirka, Victor M.
    Qi, Qi
    Fox, Matthew S.
    Kovacs, Michael S.
    Ramachandran, Rithwik
    Luyt, Leonard G.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 246
  • [4] Trypsin induces an aversive response in zebrafish by PAR2 activation in keratinocytes
    Alsrhani, Abdullah
    Raman, Revathi
    Jagadeeswaran, Pudur
    PLOS ONE, 2021, 16 (10):
  • [5] Protease-activated Receptor-2 (PAR2) in Human Periodontitis
    Holzhausen, M.
    Cortelli, J. R.
    Araujo da Silva, V.
    Nobre Franco, G. C.
    Cavalca Cortelli, S.
    Vergnolle, N.
    JOURNAL OF DENTAL RESEARCH, 2010, 89 (09) : 948 - 953
  • [6] Protease activated receptor-2 (PAR2): possible target of phytochemicals
    Kakarala, Kavita Kumari
    Jamil, Kaiser
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2015, 33 (09) : 2003 - 2022
  • [7] High Affinity Fluorescent Probe for Proteinase-Activated Receptor 2 (PAR2)
    LeSarge, Jordan C.
    Thibeault, Pierre
    Milne, Mark
    Ramachandran, Rithwik
    Luyt, Leonard G.
    ACS MEDICINAL CHEMISTRY LETTERS, 2019, 10 (07): : 1045 - 1050
  • [8] PAR2 (Protease-Activated Receptor 2) Deficiency Attenuates Atherosclerosis in Mice
    Jones, Shannon M.
    Mann, Adrien
    Conrad, Kelsey
    Saum, Keith
    Hall, David E.
    McKinney, Lisa M.
    Robbins, Nathan
    Thompson, Joel
    Peairs, Abigail D.
    Camerer, Eric
    Rayner, Katey J.
    Tranter, Michael
    Mackman, Nigel
    Owens, A. Phillip, III
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2018, 38 (06) : 1271 - 1282
  • [9] Proteolytic bacteria expansion during colitis amplifies inflammation through cleavage of the external domain of PAR2
    Rondeau, Liam Emile
    Da Luz, Bruna Barbosa
    Santiago, Alba
    Bermudez-Brito, Miriam
    Hann, Amber
    De Palma, Giada
    Jury, Jennifer
    Wang, Xuanyu
    Verdu, Elena Francisca
    Galipeau, Heather Jean
    Rolland, Corinne
    Deraison, Celine
    Ruf, Wolfram
    Bercik, Premysl
    Vergnolle, Nathalie
    Caminero, Alberto
    GUT MICROBES, 2024, 16 (01)
  • [10] Proteinase-activated Receptor 2 (PAR2) Decreases Apoptosis in Colonic Epithelial Cells
    Iablokov, Vadim
    Hirota, Christina L.
    Peplowski, Michael A.
    Ramachandran, Rithwik
    Mihara, Koichiro
    Hollenberg, Morley D.
    MacNaughton, Wallace K.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (49) : 34366 - 34377